shine-logo

medical isotopes

Home » medical isotopes

Technology Demonstration Validates Business Case

SHINE and Phoenix tested the first production-ready accelerator in SHINE’s Janesville facility over the course of 5.5 days to determine percentage uptime and total neutron output. The average system neutron yield was measured to be 10% percent beyond the required output, with greater than 99 percent uptime.

2021-12-17T17:44:56-06:00June 19, 2019|News Releases, Archived, 2019|

Grand Opening of new SHINE Global HQ

January 16, 2017 - SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

2021-12-17T18:52:45-06:00January 16, 2017|News, News Releases, Archived, 2017|

NRC Issues SHINE Construction Permit

February 25, 2016 - SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

2021-12-17T18:54:24-06:00February 25, 2016|News Releases, Archived|
Go to Top